drugset / Trial / NCT00049972

Major Depressive Disorder Study In Adults

NCT00049972

Phase 4 Completed 646 enrolled GlaxoSmithKline
Non-randomizedOpen-labelTreatment

Summary

A study to obtain safety and tolerability data

Timeline

Start
2002-09
Primary completion
2003-09
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule